Tandingan, Dolores A.

HRN: 25-81-92  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/07/2024
CEFTRIAXONE 1G (VIAL)
09/07/2024
09/14/2024
IV
2g
OD
Non Healing Wound, Left Foot
Waiting Final Action 
09/07/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
09/07/2024
09/07/2024
IV
4.5g
1 Dose LD
Non-healing Wound, Left Foot
Waiting Final Action 
09/07/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
09/07/2024
09/14/2024
IV
2.25g
Q8H
Non-healing Wound, Left Foot
Waiting Final Action 
09/23/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
09/23/2024
10/03/2024
IV
2.25g
Q6
Diabetic Foot
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: